Search for: "International Materials, Inc." Results 2061 - 2080 of 7,053
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Apr 2017, 5:00 am by Sophie Fritz
Court of Appeals for the Second District affirmed the district court's judgment, finding the allegations “wholly conclusory and materially indistinguishable from the allegations that the Supreme Court found insufficient” in Amgen Inc. v. [read post]
11 Apr 2017, 3:01 pm
Many enterprises have developed internal governance structures that embed a governance framework for CSR within their international corporate governance. [read post]
11 Apr 2017, 7:29 am by Nora Ellingsen, Lisa Daniels
We used open source material to attempt to determine the country of origin for the remaining 508 individuals. [read post]
10 Apr 2017, 6:43 am by Jordan Brunner
Please submit these materials AS ONE PDF via email to nsd.ovt@usdoj.gov. [read post]
9 Apr 2017, 4:33 pm by INFORRM
 The claim against the first defendant, Google Inc, continues. [read post]
5 Apr 2017, 2:01 pm by Heidi A. Nadel
" Since there was no evidence calling into question the independence or diligence of the special committee, the shareholder failed to meet this standard.The trial judge also reasoned that if the plaintiff had filed a derivative lawsuit, it would be subject to dismissal and all discovery would be stayed pending dismissal, so the shareholder would not be entitled to the same materials in discovery.The SJC's Decision.The SJC opened its explanation of its decision with the following… [read post]
5 Apr 2017, 2:01 pm by Heidi A. Nadel
Defendant Vertex Pharmaceuticals, Inc. develops and manufactures drugs for treatment of serious diseases.Plaintiff is a shareholder in Vertex.In the Spring of 2012, Vertex issued a press release announcing the interim results of a "phase two" study regarding the effectiveness of two of its drugs to treat cystic fibrosis. [read post]
5 Apr 2017, 2:01 pm by Heidi A. Nadel
Defendant Vertex Pharmaceuticals, Inc. develops and manufactures drugs for treatment of serious diseases.Plaintiff is a shareholder in Vertex.In the Spring of 2012, Vertex issued a press release announcing the interim results of a "phase two" study regarding the effectiveness of two of its drugs to treat cystic fibrosis. [read post]
5 Apr 2017, 1:43 pm by Cynthia Marcotte Stamer
Beyond the requirement to itemize, the Internal Revenue Code also imposes a second hurdle that further restricts the deductibility of business expenses when claimed by an employee versus a business. [read post]
3 Apr 2017, 8:54 am by Jordan Brunner
Please submit these materials AS ONE PDF via email to nsd.ovt@usdoj.gov. [read post]